Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair
Askel Healthcare, a Finnish medical technology company offering a new method for the treatment of knee cartilage defects, has established a Clinical Advisory Board (CAB) representing globally renowned orthopedic surgeons and sports medicine specialists in knee cartilage repair. The newly appointed CAB will have an instrumental advisory role in gathering of high-level clinical evidence of the broad benefits of the COPLA[®] implant and its successful commercialization. COPLA[®] is a biodegradable implant for surgical treatment of cartilage damage in the knee. In the first phase of